The use of antiplatelet agent did not modify the event rates for CAD-T2DM without prior MI or stroke patients, but was associated with a higher risk in the THEMIS-like population, and was probably more a proxy of disease severity as for diuretics and insulin above (Table 5). This evidence concerns the gene INS and coronary artery disorder.